Press release
Cell and Gene Therapy Market Projected to Grow to USD 172B by 2035
The global cell and gene therapy market is witnessing rapid expansion due to increasing clinical trials, robust regulatory support, and breakthroughs in biotechnology. Valued at USD 21.43 Billion in 2025, the market is expected to grow at a CAGR of 23.17% from 2026 to 2035, reaching USD 172.22 Billion by 2035.
Cell and gene therapies are revolutionizing modern medicine by offering targeted treatments for previously untreatable diseases, including oncology, genetic disorders, neurological conditions, and cardiovascular diseases. These therapies work by repairing, replacing, or modifying cellular or genetic material to restore normal function, offering curative potential rather than symptom management.
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/cell-and-gene-therapy-cgt-market/requestsample.
Market Overview and Current Landscape
Cell and gene therapies are advanced treatment modalities that leverage living cells and genetic modifications to treat complex diseases. The market is driven by technological innovations, increasing investment in clinical research, and expanding patient access to therapies.
Key Market Highlights
Market Value (2025): USD 21.43 Billion
Forecast Value (2035): USD 172.22 Billion
CAGR (2026-2035): 23.17%
Primary Growth Drivers:
Rising prevalence of cancer and genetic disorders
Growing number of clinical trials and regulatory approvals
Advancements in viral and non-viral vector delivery systems
Expansion of specialized treatment centers and research institutes
Factors Driving Market Growth
Breakthroughs in Cell and Gene Therapy Technologies
Autologous and allogeneic cell therapies allow personalized treatment approaches
Somatic and germline gene therapies enable targeted genetic modifications
Viral vectors (lentivirus, adenovirus) and non-viral techniques enhance efficiency and safety
Increasing Clinical Trials and Regulatory Approvals
Strong pipeline of therapies across oncology, hematology, and rare genetic diseases
Accelerated approval pathways by FDA, EMA, and PMDA
Expanded compassionate use programs increase patient access
Rising Prevalence of Chronic and Genetic Disorders
Oncology, neurological, cardiovascular, and hematological diseases are key targets
Genetic testing and early diagnosis improve patient eligibility for therapy
Growing awareness among patients and clinicians drives adoption
Expansion of Specialized Treatment Centers
Hospitals and cancer care centers with dedicated cell and gene therapy units
Academic and research institutes advancing clinical research
Centers of excellence ensure proper administration and patient monitoring
Technological Advancements in Delivery and Manufacturing
Ex vivo and in vivo delivery techniques enhance precision and reduce adverse effects
Scalable manufacturing of viral vectors and cellular products
Quality control and process automation improve therapy consistency
Challenges Limiting Market Growth
Despite significant growth, the market faces several challenges:
High Cost of Therapy
Cell and gene therapies are expensive due to complex manufacturing and regulatory compliance
Limited insurance coverage in some regions affects patient access
Manufacturing and Scalability Issues
Production of autologous therapies requires patient-specific processes
Viral vector production and ex vivo expansion require advanced facilities and expertise
Safety and Ethical Concerns
Potential immunogenicity, off-target effects, and long-term safety risks
Ethical considerations around germline gene therapy and genetic modifications
Regulatory Complexity
Multi-regional approvals and stringent safety standards
Need for harmonized global guidelines to streamline therapy availability
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/cell-and-gene-therapy-cgt-market.
Market Segmentation by Therapy Type
Cell Therapy Types
Autologous Cell Therapy: Uses patient's own cells, minimizing immune rejection
Allogenic Cell Therapy: Uses donor cells, allowing off-the-shelf treatment options
Gene Therapy Types
Somatic Gene Therapy: Alters non-reproductive cells to treat or cure diseases
Germline Gene Therapy: Genetic modifications are heritable, raising ethical concerns
Market Segmentation by Type
Cell Type
Stem Cells: Hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells
Non-Stem Cells: Immune cells (T-cells, NK cells), fibroblasts, chondrocytes
Gene Type
Antigens: Immunotherapy targets for cancer and infectious diseases
Cytokines: Enhance immune response in oncology and inflammatory diseases
Tumor Suppressor Genes: Restore normal cellular regulation
Growth Factors: Promote tissue regeneration and healing
Receptors: Targeted therapies for specific molecular pathways
Others: Novel gene constructs for rare and complex disorders
Market Segmentation by Delivery Mode
In Vivo: Direct administration into the patient, typically using viral vectors
Ex Vivo: Cells are modified outside the body and then reintroduced
Market Segmentation by Vector Type
Viral Vectors: Lentivirus, adenovirus, AAV (adeno-associated virus), retrovirus
Non-Viral Techniques: CRISPR, electroporation, lipid nanoparticles, plasmid DNA
Market Segmentation by Therapeutic Area
Oncology
CAR-T cell therapies, gene-modified T-cells, and oncolytic viruses
Rapidly growing segment due to high unmet needs in hematological and solid tumors
Cardiovascular Diseases
Gene therapies targeting heart failure, myocardial infarction, and arrhythmias
Ex vivo cell therapies for tissue repair
Neurological Disorders
Gene therapy for Parkinson's, Alzheimer's, spinal muscular atrophy, and ALS
Stem cell therapy for neurodegenerative conditions
Genetic Disorders
Rare diseases like hemophilia, cystic fibrosis, and muscular dystrophy
Personalized treatment approaches using patient-specific gene modifications
Infectious Diseases
Vaccine-based gene therapy and antigen-targeted treatments
Immunotherapies for viral infections
Hematological Disorders
Gene and cell therapy for sickle cell anemia, thalassemia, and leukemia
HSCT (hematopoietic stem cell transplantation) in combination with gene editing
Musculoskeletal Disorders
Cell therapy for osteoarthritis, cartilage regeneration, and bone repair
Others
Emerging applications in autoimmune disorders, ophthalmology, and dermatology
Market Segmentation by End User
Hospitals: Primary centers for therapy administration
Cancer Care Centers: Focus on CAR-T and immune therapies
Academic and Research Institutes: Clinical trials, novel therapies, and translational research
Others: Specialty clinics and biotech hubs providing advanced therapies
Regional Market Insights
North America
Largest market share due to strong biotech ecosystem
Regulatory support from FDA and clinical trial infrastructure
High adoption of CAR-T and gene therapies
Europe
Germany, UK, France, and Switzerland lead the market
Growing investment in clinical trials and specialized centers
Asia Pacific
Fastest-growing region with China, Japan, South Korea, and India
Expansion of manufacturing facilities and clinical research networks
Latin America
Moderate growth with focus on hematology and oncology
Emerging patient access programs and clinical trials
Middle East and Africa
Increasing healthcare infrastructure investment
Rising focus on genetic disorder therapies and oncology
Competitive Landscape
The cell and gene therapy market is highly competitive, with leading global biopharmaceutical companies and innovative biotech startups driving innovation.
Key Companies
Amgen Inc.
Novartis AG
Pfizer Inc.
Bluebird Bio, Inc.
Castle Creek Pharmaceutical Holdings
Bristol-Myers Squibb
Kite Pharma, Inc.
Vericel Corporation Inc.
Kolon TissueGene Inc.
Vertex Pharmaceuticals, Inc.
Spark Therapeutics, Inc.
CORESTEM Inc.
Biogen Inc.
Dendreon Pharmaceuticals LLC
JCR Pharmaceuticals Co. Ltd.
Strategies Adopted by Market Players
Strategic partnerships and collaborations for pipeline expansion
Investment in viral vector manufacturing and scalable ex vivo platforms
Development of novel CAR-T, TCR, and gene-editing therapies
Expansion of global treatment centers and clinical trial networks
Focus on regulatory approvals and compassionate use programs
Technological Trends in Cell and Gene Therapy
CAR-T and TCR Therapies
Engineered T-cells targeting specific cancer antigens
Personalized therapies for hematologic malignancies
CRISPR and Gene Editing
Precision editing of genetic sequences
Potential to cure rare and monogenic diseases
Advanced Viral and Non-Viral Delivery Systems
High transduction efficiency with minimal off-target effects
Improved patient safety and therapy outcomes
Ex Vivo Manufacturing Platforms
Scalable production of autologous and allogeneic cells
Automation reduces cost and improves reproducibility
Digital and AI Integration
Predictive modeling for therapy response
AI-based process optimization and patient selection
Future Outlook
The cell and gene therapy market is poised for exponential growth due to:
Increasing regulatory approvals and supportive frameworks
Expansion of clinical trials and pipeline therapies
Rising adoption of personalized and precision medicine
Growth of specialized treatment centers globally
Technological innovations in vector design, gene editing, and cell manufacturing
By 2035, the market is expected to reach USD 172.22 Billion, reflecting a CAGR of 23.17%, driven by expanding applications in oncology, rare diseases, and regenerative medicine.
Browse More Reports
United States Topical Pain Relief Market - https://bit.ly/43Fje4N.
Cough Syrup Market - https://bit.ly/4oRldLU.
Emergency Medical Services (EMS) Vehicle Market - https://bit.ly/3JwPrV9.
India Biosimilar Market - https://bit.ly/4oX4xT4.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell and Gene Therapy Market Projected to Grow to USD 172B by 2035 here
News-ID: 4313152 • Views: …
More Releases from Expert Market Research
Global CDMO Market Forecast to Hit USD 588B by 2035
What is driving the growth of the global CDMO market, and how is it expected to evolve by 2035?
The global contract development and manufacturing organization (CDMO) market is experiencing significant growth, driven by rising demand for novel drugs, biologics, and therapies to address chronic diseases worldwide. The market was valued at USD 246.11 Billion in 2025 and is projected to grow at a CAGR of 9.10% between 2026 and 2035,…
Schizophrenia Market to Reach USD 14.46B by 2035 at 5.8% CAGR
What is driving the growth of the global schizophrenia market, and how is it expected to evolve by 2035?
The global schizophrenia market is experiencing steady growth as awareness, diagnosis, and treatment of schizophrenia increase worldwide. In 2025, the market attained a value of USD 8.23 Billion, and it is projected to grow at a CAGR of 5.80% between 2026 and 2035, reaching USD 14.46 Billion by 2035.
Schizophrenia, a chronic and…
Saudi Arabia Medical Gases Market to Grow at 7.10% CAGR by 2035
What is driving the growth of the Saudi Arabia medical gases market, and what trends are shaping its future?
The Saudi Arabia medical gases market is witnessing steady growth due to the expansion of the healthcare sector, increasing adoption of advanced medical technologies, and rising demand for hospital-based and home healthcare solutions. Valued at USD 155.08 Million in 2025, the market is projected to grow at a CAGR of 7.10%, reaching…
Robotic Surgical Procedures Market to Hit USD 45.87B by 2035
What is driving the rapid rise of the global robotic surgical procedures market, and how is the industry expected to grow by 2035?
The global robotic surgical procedures market is experiencing remarkable growth as healthcare providers increasingly adopt robot-assisted surgeries for higher precision, minimal complications, and improved patient outcomes. In 2025, the market reached USD 8.26 Billion, and with technological advancements and expanded surgical applications, it is expected to grow at…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
